Advert - Pfizer and Novartis

• Date posted
  01 August 2017
• Sanction
  Advertisement,
• Case number/s
  AUTH/2928/1/17 and AUTH/2929/1/17 - Anonymous v Pfizer and Novartis

For failing to comply with their previous undertakings by continuing to misleadingly promote Ultibro Breezhaler (indacaterol/glycopyrronium) without setting that within the context of its licensed indication and for producing representatives’ briefing material that was not sufficiently clear Pfizer and Novartis were ruled in breach of the following clauses of the Code.

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry.

Clause 3.2 - Making claims inconsistent with the SPC.

Clause 7.2 - Making misleading claims as to the licensed indications of a medicine.

Clause 9.1 - Failing to maintain high standards.

Clause 15.9 - Producing representatives’ briefing material that was likely to lead to a breach of the Code.

Clause 29 - Failing to comply with an undertaking.